#USA #New York #Class Action #Levi & Korsinsky #Nutex Health Inc.

Levi & Korsinsky Alerts Nutex Health Inc. Shareholders on Class Action and Key Deadlines

On September 16, 2025, Levi & Korsinsky, LLP announced a class action securities lawsuit involving Nutex Health Inc. (NASDAQ: NUTX). The firm is actively notifying investors who may have been affected by alleged securities fraud from August 8, 2024, to August 14, 2025. This article delves into the implications of the lawsuit, the processes involved, and key deadlines investors should be aware of.

Understanding the Class Action Lawsuit

The class action aims to recover losses for Nutex Health Inc. shareholders who have encountered financial damages due to misleading company information and alleged fraudulent practices. The lawsuit outlines accusations that the company and certain defendants made false statements and concealed critical information regarding the company’s revenue and internal controls over financial reporting.

Allegations of Securities Fraud

The lawsuit asserts that Nutex Health's third-party vendor, HaloMD, engaged in dubious schemes to extract profits through fraudulent activities designed to deceive insurance companies. The lawsuit claims that:
1. Revenues reported, which were linked to Nutex's interactions with HaloMD, were unsustainable and derived from fraudulent behavior.
2. The company overstated its remediation efforts concerning identified weaknesses in its financial reporting controls.
3. Nutex inaccurately classified stock-based compensation obligations, treating them as equity instead of liabilities, increasing the likelihood of failing to file accurate financial reports with the SEC.
4. Consequently, the firm’s business outlook and financial health were overstated.

Investor Participation and Deadlines

Investors suffering losses during the specified period have an obligation to respond by October 21, 2025, to request the Court appoint them as lead plaintiffs. This step is crucial for those looking to actively engage in the lawsuit process, although participation in the recovery is not limited to lead plaintiffs.

Potential plaintiffs can contact Joseph E. Levi, Esq. through email or call at (212) 363-7500 for further inquiries or assistance regarding participation and the legal process ahead.

Why Choose Levi & Korsinsky?

Over the last two decades, Levi & Korsinsky has successfully recovered substantial sums for numerous aggrieved shareholders, establishing a reputation for tackling high-stakes securities litigation. The firm is recognized as one of the top securities litigation firms in the United States, boasting a track record of success and a dedicated team of over 70 professionals focused on serving the interests of their clients.

Conclusion

The impending deadlines and complexities surrounding the class action lawsuit against Nutex Health Inc. require immediate attention from affected investors. Levi & Korsinsky’s commitment to transparency and assistance empowers shareholders to take proactive measures in this critical time. Potential class members are encouraged to act swiftly and seek guidance to navigate the intricacies of this legal landscape effectively.

For comprehensive details on the lawsuit and how to participate, please visit the official Levi & Korsinsky website. Don't miss the chance to protect your investment rights.